Fennec Pharmaceuticals Inc. (FENC) Financials

FENC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 71.8 million 34.1 million
Dec. 31, 2025 70.1 million 35.0 million
Sept. 30, 2025 49.2 million 53.7 million
June 30, 2025 44.9 million 52.3 million

FENC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.4 million 990000
Dec. 31, 2025 -6.0 million 2.5 million
Sept. 30, 2025 1.5 million 2.2 million
June 30, 2025 -3.7 million 1.5 million

FENC Net Income

No data available :(

FENC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 40.2 million - -
Dec. 31, 2025 36.7 million - -
Sept. 30, 2025 21.9 million 18.1 million -
June 30, 2025 18.7 million 19.4 million -

FENC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 35.5 million
Dec. 31, 2025 31.2 million
Sept. 30, 2025 27.9 million
June 30, 2025 27.7 million

FENC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1 48999 14.6 million 11.4 million
Dec. 31, 2025 - 20000 14.5 million 6.1 million
Sept. 30, 2025 - 29000 12.0 million 5.2 million
June 30, 2025 - 107000 11.3 million 4.4 million

FENC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 15.1 million 570000
Dec. 31, 2025 13.8 million 1.8 million
Sept. 30, 2025 12.5 million 660000
June 30, 2025 9.7 million 967000

FENC

Price: $9.99

52 week price:
5.65
11.31

Earnings Per Share: -0.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 138134

Ebitda: -2.2 million

Market Capitalization: 305.8 million

Links: